NA
Antiarrhythmic drugs-clinical use and clinical decision making: A consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP) / Dan, Gheorghe-Andrei; Martinez-Rubio, Antoni; Agewall, Stefan; Boriani, Giuseppe; Borggrefe, Martin; Gaita, Fiorenzo; Van Gelder, Isabelle; Gorenek, Bulent; Kaski, Juan Carlos; Kjeldsen, Keld; Lip, Gregory Y. H.; Merkely, Bela; Okumura, Ken; Piccini, Jonathan P.; Potpara, Tatjana; Poulsen, Birgitte Klindt; Saba, Magdi; Savelieva, Irina; Tamargo, Juan L.; Wolpert, Christian; Sticherling, Christian; Ehrlich, Joachim R.; Schilling, Richard; Pavlovic, Nikola; De Potter, Tom; Lubinski, Andrzej; Svendsen, Jesper Hastrup; Ching, Keong; Sapp, John Lewis; Chen-Scarabelli, Carol; Martinez, Felipe. - In: EUROPACE. - ISSN 1099-5129. - 20:5(2018), pp. 731-732. [10.1093/europace/eux373]
Antiarrhythmic drugs-clinical use and clinical decision making: A consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)
Boriani, Giuseppe;
2018
Abstract
NAFile | Dimensione | Formato | |
---|---|---|---|
eux373.pdf
Accesso riservato
Tipologia:
VOR - Versione pubblicata dall'editore
Dimensione
4.77 MB
Formato
Adobe PDF
|
4.77 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris